Effect of HER2 protein expression on the prognosis of breast cancer

GAO Wei; SHAO Junjun; ZHU Jingrui; WANG Yimin

PDF(793 KB)

Anhui Journal of Preventive Medicine ›› 2019, Vol. 25 ›› Issue (6) : 484-486.

Effect of HER2 protein expression on the prognosis of breast cancer

GAO Wei, SHAO Junjun, ZHU Jingrui, WANG Yimin

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

GAO Wei, SHAO Junjun, ZHU Jingrui, WANG Yimin. Effect of HER2 protein expression on the prognosis of breast cancer[J]. Anhui Journal of Preventive Medicine. 2019, 25(6): 484-486

References

[1] 刘尧,刘月平,刘俊英,等.FoxM1与BCRP在非特殊型浸润性乳腺癌中的表达及其预后意义[J].中华病理学杂志,2017,46(1):30-33.
[2] 刘劲,李薇,段华新,等.初发急性白血病患者骨髓乳腺癌耐药蛋白基因表达及其与预后关系的研究[J].中国现代医学杂志,2018,28(12):55-58.
[3] 熊志勇,吴珏堃,林良奕.KDM5B基因在乳腺癌中的表达及其临床意义[J].中国病理生理杂志,2018,34(12):94-97.
[4] 李红蕾,由法平,卜庆敖,等.术前dNLR值与HER-2阳性乳腺癌患者预后的关系[J].山东医药,2018,1099(25):69-71.
[5] 王倩,孙冰,孟祥颖,等.乳腺癌单纯骨转移患者预后相关因素分析[J].中华肿瘤防治杂志,2018,25(5):57-62.
[6] 李杰宝,喻晓程,田野.乳腺癌分子分型与临床病理参数的关系及预后[J].中华实验外科杂志,2018,35(6):1027-1029.
[7] 裴蓓,成琳.不同分子分型乳腺癌患者预后与淋巴结转移率的相关性分析[J].中国肿瘤生物治疗杂志,2019,26(7):776-781.
[8] Slamon DJ,Crown J,Lang I,et al.Long-term safety profile of palbociclib (P) in combination with letrozole (L) as first-line treatment for postmenopausal patients with ER+ and HER2-advanced breast cancer (ABC) (PALOMA-1/TRIO-18)[J].J Clin Oncol,2015;33(Suppl 1).
[9] 丁宇,翟怡,胡玮,等.乳腺癌患者术后劳动能力与手术因素的相关性[J].中国老年学杂志,2019,39(1):45-49.
[10] 陈迪,彭伟强,黄宇康.Fascin在乳腺癌组织中的表达及与患者预后的关系[J].广东医学,2018,2(1):2308-2311.
[11] 杨艳芳,姜战胜,顾林.HER2阳性乳腺癌治疗的研究进展[J].中国肿瘤生物治疗杂志,2018,25(11):118-122.
[12] 孙向洁,左珂,唐绍娴,等.雄激素受体在浸润性乳腺癌中的表达及其与乳腺癌分子分型的关系[J].中华病理学杂志,2017,46(7):476-480.